A collaboration between Medical-Objects and Valentia Technologies is set to increase the range of HL7 secure health information exchange options available in the New Zealand market.
The joint initiative will enable HL7 2.4 standards-based messages to flow between users of the Medical-Objects messaging network and Valentia's indici PMS software users. Both companies will use New Zealand’s Health Information Standards Organisations (HISO) HL7 standards and Health Provider Index (HPI) identifiers to ensure that open standards-based messages are produced and transferred.
Medical-Objects specialises in real-time health information exchange between health providers, and its network services more than 68,000 connected users across Australia and New Zealand. Medical-Objects entered the New Zealand market in 2018, initially working with Pathlab to deliver real-time pathology results to referring GPs in the Midlands region.
Valentia Technologies is focused on developing cloud-based solutions for healthcare services that are delivered in out-of-hospital settings, including in the home. Valentia’s indici PMS solution for general practice and allied health services has been extensively integrated with wider New Zealand healthcare and is experiencing accelerating adoption by GPs across New Zealand.
Medical-Objects CEO, Lynden Crawford, stated, “Our success is based on our strong commitment to HL7 standards and providing users with the newest technology, support and services at an attractive cost. We have been very warmly received by the New Zealand healthcare community and we are committed to expanding our presence here. Our collaboration with Valentia represents an important expansion in our service offerings here.”
Dr Ahmed Javad, President Technical Services of Valentia Technologies, commented, “There is a growing demand within New Zealand healthcare for the adoption of standards-based, enhanced clinical messaging. Our collaboration with Medical-Objects demonstrates our commitment to promote interoperability involving the practical adoption of new HL7 2.4 standards. We will continue to pursue collaborations with healthcare messaging vendors to ensure that New Zealand maintains its leadership role in this space.”